{"id":"NCT00473668","sponsor":"GlaxoSmithKline","briefTitle":"Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib","officialTitle":"Non-inferiority of One Formulation of GSK Biologicals' DTPw-HBV/Hib to 2 Formulations of GSK Biologicals' DTPw-HBV/Hib With Respect to the Immune Response to the PRP Antigen, When Administered to Healthy Infants at 6, 10, 14 Weeks of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-06-01","primaryCompletion":"2008-01-30","completion":"2008-01-30","firstPosted":"2007-05-15","resultsPosted":"2017-08-18","lastUpdate":"2017-08-18"},"enrollment":300,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Whole Cell Pertussis","Haemophilus Influenzae Type b","Tetanus","Diphtheria","Hepatitis B"],"interventions":[{"type":"BIOLOGICAL","name":"Zilbrix-Hib","otherNames":[]},{"type":"BIOLOGICAL","name":"Tritanrix™-HepB/ Hiberix™","otherNames":[]}],"arms":[{"label":"TRITANRIX-HEPB/HIBERIX KFT. GROUP","type":"EXPERIMENTAL"},{"label":"TRITANRIX-HEPB/HIBERIX LD GROUP","type":"ACTIVE_COMPARATOR"},{"label":"TRITANRIX-HEPB/HIBERIX HD GROUP","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this observer-blind study is to generate immunogenicity data with one formulation of GSK Biologicals' DTPw-HBV/Hib vaccine after the primary vaccination course and to demonstrate non-inferiority of this vaccine as compared to two formulations of GSK Biologicals' DTPw-HBV/Hib vaccine with respect to the anti-PRP antibody response. Additionally to assess the reactogenicity and safety of GSK Biologicals' DTPw-HBV/Hib vaccine. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.","primaryOutcome":{"measure":"Number of Seroprotected Subjects Against Polyribosyl-ribitol-phosphate (PRP) Antigens","timeFrame":"At Month 3","effectByArm":[{"arm":"Tritanrix-HepB/Hiberix Kft. Group","deltaMin":93,"sd":null},{"arm":"Tritanrix-HepB/Hiberix LD Group","deltaMin":84,"sd":null},{"arm":"Tritanrix-HepB/Hiberix HD Group","deltaMin":89,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"6 Weeks","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":15},"locations":{"siteCount":3,"countries":["India"]},"refs":{"pmids":["20950457"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":100},"commonTop":["Pain","Swelling (mm)","Redness (mm)","Fever (Axillary)","Irritability"]}}